Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 81
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Technol Cancer Res Treat ; 10(2): 187-95, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21381797

RESUMEN

The purpose of this study was to evaluate acute toxicity of craniospinal irradiation (CSI) using helical tomotherapy (HT) and compare its dose distribution with that of conventional linac-based plans. Twelve patients with various brain tumors were treated with HT-CSI. Median patient age was 14 years (range: 4-37 years). Median CSI dose was 30.6 Gy in 18 fractions (range: 23.4-40 Gy in 13-25 fractions). Toxicities were assessed according to the Common Terminology Criteria for Adverse Events version 4.0. Before CSI, 11 patients (92%) received neoadjuvant chemotherapy, so acute toxicity was evaluated by comparing patient status before and after CSI. HT-CSI plans were compared with linac-based CSI plans made using Pinnacle(3) planning system in 9 patients. All patients completed planned CSI without interruption. Grade 3 or higher toxicities were leukopenia seen in 11 patients (92%), anorexia in 6 (50%), anemia in 5 (42%), and thrombopenia in 5 (42%). Administration of granulocyte colony-stimulating factor, platelet transfusion and total parenteral nutrition were required in 8 (67%), 5 (42%) and 5 (42%) patients, respectively. HT plans were superior to linac-based plans in terms of homogeneity and conformality in planning target volume (PTV). For most organs at risk (OARs), volumes receiving more than 10 Gy (V10 Gy) or 20 Gy (V20 Gy) were lower in HT plans. However, HT plans significantly increased mean doses to the lung, kidneys and liver, and V5 Gy of 6 OARs including the lung. Despite intensive neoadjuvant chemotherapy, acute toxicity of HT-CSI was acceptable. HT provided better dose distribution in PTV than conventional linac. In most OARs, smaller volumes received >10-20 Gy in HT plans, although larger volumes received 5-10 Gy.


Asunto(s)
Neoplasias Encefálicas/radioterapia , Irradiación Craneana/métodos , Planificación de la Radioterapia Asistida por Computador/métodos , Radioterapia de Intensidad Modulada/métodos , Tomografía Computarizada Espiral/métodos , Adolescente , Adulto , Neoplasias Encefálicas/tratamiento farmacológico , Niño , Preescolar , Irradiación Craneana/efectos adversos , Supervivencia sin Enfermedad , Femenino , Humanos , Masculino , Terapia Neoadyuvante , Dosis de Radiación , Radioterapia de Intensidad Modulada/efectos adversos , Resultado del Tratamiento , Adulto Joven
6.
Surg Endosc ; 21(7): 1126-30, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17180276

RESUMEN

BACKGROUND: This investigation, using the nerve conduction study, aimed to quantify the degree of laparoscopic surgeon's thumb, and to evaluate the effect of the ringed silicon rubber attachment (RSRA) developed by the authors. METHODS: For the study, 26 residents or students performed surgical tasks (grasping and dissecting) using both the laparoscopic forceps with RSRA and the conventional instrument. The paresthesia was evaluated with a severity score obtained by interview and measurement of sensory nerve conduction velocity (SCV). RESULTS: The mean severity score was 2.57 +/- 0.58 m/s for the conventional forceps and 1.05 +/- 0.80 m/s for the forceps with RSRA (p < 0.01). For the grasping task with the conventional forceps, the mean SCV was 58.3 +/- 2.81 m/s before and 54.8 +/- 2.83 m/s after the task (p < 0.01), whereas for the dissecting task, the corresponding values were 57.5 +/- 2.46 m/s and 56.1 +/- 2.93 m/s (p < 0.01). For the grasping task with the RSRA, the mean SCV was 57.1 +/- 3.33 m/s before and 55.9 +/- 3.18 m/s after the task (p < 0.01), whereas for the dissecting task, the corresponding values were 55.7 +/- 4.59 m/s and 55.8 +/- 3.50 m/s (nonsignificant difference). CONCLUSIONS: Laparoscopic surgeon's thumb was induced by compression of the lateral digital nerve. The RSRA significantly reduced the degree of paresthesia.


Asunto(s)
Ergonomía , Laparoscopios/efectos adversos , Parestesia/prevención & control , Adulto , Trastornos de Traumas Acumulados/prevención & control , Electromiografía , Diseño de Equipo , Femenino , Humanos , Internado y Residencia , Laparoscopía/efectos adversos , Laparoscopía/métodos , Masculino , Conducción Nerviosa/fisiología , Parestesia/etiología , Goma , Muestreo , Sensibilidad y Especificidad , Silicio , Análisis y Desempeño de Tareas , Pulgar
7.
Neurology ; 67(3): 531-3, 2006 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-16894125

RESUMEN

A subclass of sporadic Creutzfeldt-Jakob disease (sCJD) characterized by onset with visual symptoms (Heidenhain variant) has been reported to belong to the MM1 or MV1 type according to Parchi's classification. The authors report a 65-year-old woman with MM2-cortical sCJD with slowly progressive visual disturbance as the initial symptom. Diffusion-weighted MRIs revealed hyperintensity in both occipital cortices at an early stage.


Asunto(s)
Síndrome de Creutzfeldt-Jakob/complicaciones , Trastornos de la Visión/etiología , Anciano , Síndrome de Creutzfeldt-Jakob/clasificación , Síndrome de Creutzfeldt-Jakob/genética , Análisis Mutacional de ADN , Femenino , Humanos
8.
Br J Radiol ; 79(944): e45-9, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16861317

RESUMEN

A case of radiation myelopathy after radioactive iodine therapy is reported. This is the first report to describe radiation myelopathy after I-131 therapy. A 62-year-old female with spinal metastasis of T10 received I-131 therapy. She presented with radiation myelopathy 34 months after the irradiation. We need to recognize the possibility of this serious complication even in the case of I-131 therapy. There is a risk of radiation myelopathy even after I-131 therapy, especially in cases with spinal cord compression such as this.


Asunto(s)
Radioisótopos de Yodo/efectos adversos , Traumatismos por Radiación/etiología , Compresión de la Médula Espinal/etiología , Médula Espinal/efectos de la radiación , Neoplasias de la Columna Vertebral/secundario , Neoplasias de la Tiroides , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Debilidad Muscular/etiología , Parálisis/etiología , Trastornos de la Sensación/etiología , Compresión de la Médula Espinal/cirugía , Neoplasias de la Columna Vertebral/diagnóstico , Neoplasias de la Columna Vertebral/radioterapia
11.
Neurology ; 63(11): 2149-52, 2004 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-15596767

RESUMEN

The authors report an unusual family with hereditary spastic paraplegia (HSP) with frontal lobe dysfunction having the onset in the sixth decade. All the patients showed hypoperfusion in the frontal lobes and thalami on SPECT. Neuropathologic findings revealed thin corpus callosum and degeneration in the thalamic dorsomedial nuclei as well as degeneration of the corticospinal tracts. This family was likely affected by a novel form of HSP characterized by frontal lobe dysfunction caused by thalamic degeneration.


Asunto(s)
Demencia/etiología , Lóbulo Frontal/patología , Paraplejía Espástica Hereditaria/patología , Tálamo/patología , Adulto , Edad de Inicio , Anciano , Atrofia , Demencia/patología , Progresión de la Enfermedad , Resultado Fatal , Femenino , Lóbulo Frontal/diagnóstico por imagen , Lóbulo Frontal/fisiopatología , Gliosis/etiología , Humanos , Imagen por Resonancia Magnética , Trastornos de la Memoria/etiología , Trastornos de la Memoria/patología , Persona de Mediana Edad , Trastornos del Humor/etiología , Trastornos del Humor/patología , Tractos Piramidales/patología , Índice de Severidad de la Enfermedad , Paraplejía Espástica Hereditaria/complicaciones , Paraplejía Espástica Hereditaria/diagnóstico por imagen , Paraplejía Espástica Hereditaria/fisiopatología , Tálamo/diagnóstico por imagen , Tomografía Computarizada de Emisión de Fotón Único
13.
Int J Mol Med ; 10(5): 569-73, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12373293

RESUMEN

Lichen planus (LP), common mucocutaneous disorder, involves not only oral mucosa and skin but genitalia membrane. LP is frequently seen in patients with HCV infection. This study evaluated patients with HCV-associated oral lichen planus (OLP) for vulvar and vaginal LP involvement, and the possible intraspousal transmission of HCV. We examined a total of 24 female Japanese patients with OLP for genitalia LP: 14 OLP-HCV positive and 10 OLP-HCV negative. All subjects were evaluated for genital LP by a gynecologist. All 24 subjects and 10 of the husbands were tested for anti-HCV and serum HCV RNA. Vulvar LP was observed in 10 (41.7%) of 24 patients with OLP. Vulvar LP in 14 (OLP-HCV positive) and 10 patients (OLP-HCV negative) were observed in 42.9 and 40%, respectively. There were no significant differences (age, sites of OLP, blood transfusion, HCV infection, and degree of liver diseases) between the vulvar LP and non-vulvar LP patients. Two spouses of 10 married couples were shown to be infected with HCV. In one couple with HCV infection, the wife and husband had also erosive OLP, the wife had erosive vulvar LP. In conclusion, the majority of OLP patients suffered from genitalia LP in Japan. Clinicians should follow the OLP patients with sufficient attention to the presence of extraoral manifestations. These data may suggest the occurrence of intraspousal transmission of HCV through erosive vulvar LP.


Asunto(s)
Hepatitis C/complicaciones , Hepatitis C/transmisión , Liquen Plano Oral/complicaciones , Liquen Plano Oral/virología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Enfermedades de los Genitales Femeninos/complicaciones , Enfermedades de los Genitales Femeninos/virología , Hepatitis C/virología , Humanos , Japón , Liquen Plano/complicaciones , Liquen Plano/virología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Parejas Sexuales , Esposos
14.
J Hum Genet ; 46(11): 649-55, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11721884

RESUMEN

Autosomal recessive distal myopathy or Nonaka distal myopathy (NM) is characterized by its unique distribution of muscular weakness and wasting. The patients present with spared quadriceps muscles even in a late stage of the disease. The hamstring and tibialis anterior muscles are affected severely in early adulthood. We have localized the NM gene to the region between markers D9S319 and D9S276 on chromosome 9 by linkage analysis. To further refine the localization of the NM gene, we conducted homozygosity and linkage disequilibrium analysis for 14 patients from 11 NM families using 18 polymorphic markers. All of the patients from consanguineous NM families were found to be homozygous for six markers located within the region between markers D9S2178 and D9S1859. We also provided evidence for significant allelic associations between the NM region and five marker loci. Examination of the haplotype analysis identified a predominant ancestral haplotype comprising the associated alleles 199-160-154-109 (marker order: D9S2179-D9S2180-D9S2181-D9S1804), present in 60% of NM chromosomes and in 0% of parent chromosomes. On the basis of the data obtained in this study, the majority of NM chromosomes were derived from a single ancestral founder, and the NM gene is probably located within the 1.5-Mb region between markers D9S2178 and D9S1791.


Asunto(s)
Cromosomas Humanos Par 9 , Genes Recesivos , Desequilibrio de Ligamiento , Distrofias Musculares/genética , Adulto , Alelos , Mapeo Cromosómico , Consanguinidad , Cartilla de ADN , Femenino , Marcadores Genéticos , Haplotipos/genética , Homocigoto , Humanos , Masculino , Distrofias Musculares/clasificación , Polimorfismo Genético
16.
Biosci Biotechnol Biochem ; 65(8): 1849-51, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11577726

RESUMEN

The natural quinone, hydroxydietrichequinone (3-heptadec-8-enyl-2-hydroxy-5-methoxy-[1,4]benzoquinone) is a secondary metabolite of Cyperus javanicus. We found that this quinone inhibited both mitochondrial respiration and photosynthesis in their electron transportation systems. The quinone was found to have a mode of action against the ubiquinone reductase site from the results of different electron donor experiments on intact mitochondria from rat liver. The electron transport system, photosystem-II (PS-II), in chroloplast from spinach leaves was inhibited by the quinone in a similar way to that of the triazin sires herbicide, atrazin, with its mode of action against PS II. This natural quinone has a long aliphatic chain (C17) including an unsaturated bond at its midpoint. We recognized 8-9 unsaturated bonds in the aliphatic chain from an MS analysis of the methylthio-addact, and spectral data presumed a configuration of cis. form.


Asunto(s)
Benzoquinonas/farmacología , Cyperaceae/química , Transporte de Electrón/efectos de los fármacos , Plantas Medicinales/química , Animales , Benzoquinonas/química , Benzoquinonas/aislamiento & purificación , Cromatografía en Capa Delgada , Técnicas In Vitro , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/enzimología , Mitocondrias Hepáticas/metabolismo , Consumo de Oxígeno/efectos de los fármacos , Ratas , Ratas Wistar , Espectrofotometría Infrarroja
17.
Jpn J Clin Oncol ; 31(8): 395-8, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11574633

RESUMEN

BACKGROUND: Intensifying the dose of paclitaxel given in a weekly schedule is useful towards improving the therapeutic index of paclitaxel in treating a variety of advanced and recurrent malignancies and is suitable for outpatient administration. This pilot study was carried out to evaluate the safety of weekly paclitaxel administration by 1 h infusion in the outpatient setting. METHODS: Eleven patients with recurrent gynecological tumors who had previously been treated with at least one platinum-based chemotherapy regimen participated in the study between May 1999 and March 2000. Paclitaxel was given at a dose of 70 mg/m(2 ) as a 1 h infusion every week for at least 20 consecutive weeks unless lesions became progressive. Intravenous dexamethasone and cimetidine and oral diphenhydramine were administered 30 min before paclitaxel infusion. RESULTS: The 11 patients received a total of 166 cycles of therapy. All patients received 70 mg/m(2 ) doses of paclitaxel without treatment delay. No hypersensitivity reactions were elicited. Grade 3 or 4 leukopenia and neutropenia occurred in 9 and 36% of the patients, respectively. Granulocyte colony-stimulating factor was required for only one patient and no patients experienced febrile neutropenia. Neurotoxicity was the most serious adverse effect and all patients experienced grade 1 or 2 peripheral neuropathy. Grade 1 or 2 myalgias were observed in 45% of the patients. Alopecia was universal. No Grade 3 or higher non-hematological toxicities were observed. CONCLUSION: Weekly 1 h paclitaxel administration is considered safe as a salvage therapy for recurrent gynecological tumors, making its use more convenient and easier in the outpatient setting. The current results support further evaluation.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Neoplasias de los Genitales Femeninos/tratamiento farmacológico , Paclitaxel/administración & dosificación , Atención Ambulatoria , Esquema de Medicación , Neoplasias Endometriales/tratamiento farmacológico , Femenino , Humanos , Infusiones Intravenosas , Recurrencia Local de Neoplasia/tratamiento farmacológico , Neoplasias Ováricas/tratamiento farmacológico , Proyectos Piloto , Calidad de Vida , Terapia Recuperativa , Neoplasias del Cuello Uterino/tratamiento farmacológico
18.
EMBO J ; 20(16): 4618-27, 2001 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-11500387

RESUMEN

M-phase promoting factor is a complex of cdc2 and cyclin B that is regulated positively by cdc25 phosphatase and negatively by wee1 kinase. We isolated the wee1 gene promoter and found that it contains one AP-1 binding motif and is directly activated by the immediate early gene product c-Fos at cellular G(1)/S phase. In antigen-specific Th1 cells stimulated by antigen, transactivation of the c-fos and wee1 kinase genes occurred sequentially at G(1)/S, and the substrate of wee1 kinase, cdc2-Tyr15, was subsequently phosphorylated at late G(1)/S. Under prolonged expression of the c-fos gene, however, the amount of wee1 kinase was increased and its target cdc2 molecule was constitutively phosphorylated on its tyrosine residue, where Th1 cells went into aberrant mitosis. Thus, an immediate early gene product, c-Fos/AP-1, directly transactivates the wee1 kinase gene at G(1)/S. The transient increase in c-fos and wee1 kinase genes is likely to be responsible for preventing premature mitosis while the cells remain in the G(1)/S phase of the cell cycle.


Asunto(s)
Proteínas de Ciclo Celular , Mitosis/fisiología , Proteínas Nucleares , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas c-fos/metabolismo , Factor de Transcripción AP-1/metabolismo , Activación Transcripcional , Animales , Antígenos/inmunología , Sitios de Unión , Ciclo Celular , Línea Celular Transformada , Fase G1 , Ratones , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas c-fos/genética , Fase S , Células TH1/citología
19.
Biosci Biotechnol Biochem ; 65(7): 1534-41, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11515536

RESUMEN

Photoreactive derivatives of imidacloprid and its nitromethylene analogue were synthesized as candidate photoaffinity probes for identifying the amino acid residues of nicotinic acetylcholine receptors (nAChRs) that interact with the neonicotinoid insecticides. When the candidate probes were injected into American cockroaches, the nerve cord neural activity initially increased, then ceased and death of the insect followed. Both the nerve cord and toxicity were enhanced by changing the photoreactive substituent from the para position to the meta position on the spacer benzyl moiety. When tested on a Drosophila SAD/chicken beta2 hybrid, recombinant nAChR expressed in Xenopus oocytes, the nitromethylene candidate probes showed agonist activity similar to that previously observed for imidacloprid.


Asunto(s)
Anabasina/metabolismo , Insecticidas/farmacología , Sistema Nervioso/efectos de los fármacos , Sistema Nervioso/metabolismo , Etiquetas de Fotoafinidad/farmacología , Animales , Sitios de Unión , Drosophila , Femenino , Técnicas In Vitro , Insecticidas/síntesis química , Insecticidas/química , Oocitos/metabolismo , Periplaneta , Etiquetas de Fotoafinidad/síntesis química , Etiquetas de Fotoafinidad/química , Receptores Nicotínicos/efectos de los fármacos , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Xenopus laevis
20.
Int J Gynecol Cancer ; 11(2): 167-8, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11328417

RESUMEN

We report the use of paclitaxel in the successful treatment of a patient with recurrent adenocarcinoma of the cervix. Paclitaxel, 70 mg/m2 by 1-h infusion weekly, was administered to a 59-year-old patient with cervical adenocarcinoma showing lung metastasis. She showed partial clinical response after seven cycles, and at the completion of 20 cycles she showed complete response, which was confirmed by chest X-ray and computed tomography scan. Toxicities including neurotoxicity were mild. She showed an objective response to treatment for over 8 months, and she enjoyed a favorable quality of life during and after treatment. Weekly paclitaxel was very well tolerated, yet was effective for recurrent cervical adenocarcinoma.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/secundario , Antineoplásicos Fitogénicos/uso terapéutico , Neoplasias Pulmonares/secundario , Paclitaxel/uso terapéutico , Neoplasias del Cuello Uterino/tratamiento farmacológico , Adenocarcinoma/patología , Antineoplásicos Fitogénicos/administración & dosificación , Esquema de Medicación , Femenino , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia/tratamiento farmacológico , Paclitaxel/administración & dosificación , Neoplasias del Cuello Uterino/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...